H.R. 172House117th Congress (2021-2023)Passed House

United States Anti-Doping Agency Reauthorization Act of 2021

Introduced January 4, 2021

AI-Generated Summary

Updated February 7, 2026 at 9:00 PM UTC

The United States Anti‑Doping Agency Reauthorization Act of 2021 renews USADA’s authority and provides increased funding through 2030. It expands USADA’s role to certify international testing, adds a youth‑sport education component, and ensures due‑process rights in enforcement actions. The bill also requires key federal agencies to share anti‑doping information with USADA.

Key Provisions

  • Amends the law to formally recognize USADA as the independent national anti‑doping organization for U.S. amateur Olympic and Paralympic sport and to require it to certify any international testing done under the World Anti‑Doping Code within the United States.
  • Adds a new duty for USADA to use part of its funding to create and distribute educational materials that promote sportsmanship, character building, and healthy performance for youth athletes, parents, and coaches.
  • Requires that any USADA enforcement action that involves a violation of federal law must provide due‑process protections to the person affected.
  • Sets specific annual funding levels for USADA from fiscal year 2022 through 2030, ranging from $15.5 million in 2022 to $24.9 million in 2029.
  • Mandates that the Attorney General, the Secretary of Homeland Security, and the FDA share relevant anti‑doping information with USADA, except where prohibited by law or when it would compromise a criminal investigation.

Legislative Activity

Stay on top of the latest movement without scrolling through every action

11 earlier actions
SenateIntro Referral Latest Action

Received in the Senate and Read twice and referred to the Committee on Commerce, Science, and Transportation.

April 15, 2021

View full timeline
HouseIntro Referral

Introduced in House

January 4, 2021

HouseIntro Referral

Referred to the House Committee on Energy and Commerce.

January 4, 2021

HouseCommittee

Referred to the Subcommittee on Health.

February 2, 2021

HouseFloor

Mr. Pallone moved to suspend the rules and pass the bill.

April 14, 2021 • 12:28 PM

HouseFloor

Considered under suspension of the rules. (consideration: CR H1748-1750)

April 14, 2021 • 12:29 PM

HouseFloor

DEBATE - The House proceeded with forty minutes of debate on H.R. 172.

April 14, 2021 • 12:29 PM

HouseFloor

At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.

April 14, 2021 • 12:37 PM

HouseFloor

Considered as unfinished business. (consideration: CR H1781-1782)

April 14, 2021 • 4:06 PM

HouseFloor

Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 381 - 37 (Roll no. 99).(text: CR H1748)

April 14, 2021 • 4:43 PM

HouseFloor

On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 381 - 37 (Roll no. 99). (text: CR H1748)

April 14, 2021 • 4:43 PM

HouseFloor

Motion to reconsider laid on the table Agreed to without objection.

April 14, 2021 • 4:43 PM

SenateIntro Referral

Received in the Senate and Read twice and referred to the Committee on Commerce, Science, and Transportation.

April 15, 2021

Floor Debate

5 members

What members said about H.R. 172 on the floor

3 Republicans2 Democrats
Frank Pallone, Jr.
Rep. Frank Pallone, Jr.D-NJ-6 · Apr 14, 2021

Mr. Speaker, I move to suspend the rules and pass the bill (H.R. 172) to reauthorize the United States Anti-Doping Agency, and for other purposes. Mr. Speaker, I ask unanimous consent that all…

Cathy McMorris Rodgers
Rep. Cathy McMorris RodgersR-WA-5 · Apr 14, 2021

Mr. Speaker, I yield myself such time as I may consume. Mr. Speaker, today I rise to speak in support of H.R. 172, the United States Anti-Doping Agency Reauthorization Act, sponsored by…

Bill Johnson
Rep. Bill JohnsonR-OH-6 · Apr 14, 2021

Mr. Speaker, I rise today in support of the U.S. Anti-Doping Agency Reauthorization Act. I thank my colleague, Representative Thompson, for his hard work to get this important legislation across the…

Mike Thompson
Rep. Mike ThompsonD-CA-5 · Apr 14, 2021

Mr. Speaker, I rise today in strong support of H.R. 172, bipartisan legislation reauthorizing the United States Anti-Doping Agency, USADA. Since 2001, USADA has been recognized by Congress as the…

Dan Bishop
Rep. Dan BishopR-NC-9 · Apr 14, 2021

Mr. Speaker, on that I demand the yeas and nays.

Bill Text

3 versions available

Reading Mode
Latest
Referred in SenateIssued April 15, 2021

IIB

117th CONGRESS

1st Session

H. R. 172

IN THE SENATE OF THE UNITED STATES

April 15, 2021

Received; read twice and referred to the Committee on Commerce, Science, and Transportation

AN ACT

To reauthorize the United States Anti-Doping Agency, and for other purposes.

1.

Short title

This Act may be cited as the United States Anti-Doping Agency Reauthorization Act of 2021.

2.

Findings

Congress makes the following findings:

(1)

The United States Anti-Doping Agency—

(A)

is the independent national anti-doping organization of the United States; and

(B)

manages the anti-doping program, results management processes, drug reference resources, and athlete education for all United States Olympic Committee-recognized national governing bodies and the athletes and events of such national governing bodies.

(2)

The United States Anti-Doping Agency contributes to the advancement of clean sport through scientific research, anti-doping education, and outreach programs, and the mission of the United States Anti-Doping Agency is to preserve the integrity of competition and protect the rights of athletes.

(3)

Participation in youth sports has the potential to equip young athletes with important skills and values necessary for success in life, and it is essential that the culture of youth sports emphasizes such skills and values.

(4)

The TrueSport program of the United States Anti-Doping Agency partners with youth sport organizations across the United States to promote sportsmanship, character building, and healthy performance through the use of targeted educational materials designed to promote a positive youth sport experience.

(5)

In modifying the authority of the United States Anti-Doping Agency to include the promotion of the positive values of youth sport, Congress sends a strong signal that the goals of youth sport should include instilling in young athletes the values of integrity, respect, teamwork, courage, and responsibility.

(6)

Due to the unique leadership position of the United States in the global community, adequate funding of the anti-doping and clean sport programs of the United States Anti-Doping Agency is imperative to the preparation for the 2028 Summer Olympic Games, which will be held in Los Angeles, California.

(7)

Increased appropriations for fiscal years 2022 through 2030 would enable the United States Anti-Doping Agency to directly affect the integrity and well-being of sport, both domestically and internationally.

3.

Modifications of authority

Section 701 of the Office of National Drug Control Policy Reauthorization Act of 2006 (21 U.S.C. 2001) is amended—

(1)

in subsection (b)—

(A)

by amending paragraph (1) to read as follows:

(1)
(A)

serve as the independent anti-doping organization for the amateur athletic competitions recognized by the United States Olympic and Paralympic Committee;

(B)

be responsible for certifying in advance any testing conducted by international organizations under the World Anti-Doping Code for international amateur athletes and athletic competitions occurring within the jurisdiction of the United States; and

(C)

be recognized worldwide as the independent national anti-doping organization for the United States;

;

(B)

in paragraph (4), by striking the period at the end and inserting ; and; and

(C)

by adding at the end the following:

(5)

promote a positive youth sport experience by using a portion of the funding of the United States Anti-Doping Agency to provide educational materials on sportsmanship, character building, and healthy performance for the athletes, parents, and coaches who participate in youth sports.

; and

(2)

by adding at the end the following:

(c)

Due process in arbitration proceedings

Any action taken by the United States Anti-Doping Agency to enforce a policy, procedure, or requirement of the United States Anti-Doping Agency against a person with respect to a violation of Federal law, including an investigation, a disciplinary action, a sanction, or any other administrative action, shall be carried out in a manner that provides due process protection to the person.

.

4.

Authorization of appropriations

Section 703 of the Office of National Drug Control Policy Reauthorization Act of 2006 (21 U.S.C. 2003) is amended to read as follows:

703.

Authorization of appropriations

There are authorized to be appropriated to the United States Anti-Doping Agency—

(1)

for fiscal year 2022, $15,500,000;

(2)

for fiscal year 2023, $16,200,000;

(3)

for fiscal year 2024, $16,900,000;

(4)

for fiscal year 2025, $17,700,000;

(5)

for fiscal year 2026, $18,500,000;

(6)

for fiscal year 2027, $19,800,000;

(7)

for fiscal year 2028, $22,100,000;

(8)

for fiscal year 2029, $24,900,000; and

(9)

for fiscal year 2030, $23,700,000.

.

5.

Information sharing

Except as otherwise prohibited by law and except in cases in which the integrity of a criminal investigation would be affected, pursuant to the obligation of the United States under Article 7 of the United Nations Educational, Scientific, and Cultural Organization International Convention Against Doping in Sport done at Paris October 19, 2005, and ratified by the United States in 2008, the Attorney General, the Secretary of Homeland Security, and the Commissioner of Food and Drugs shall provide to the United States Anti-Doping Agency any relevant information relating to the prevention of the use of performance-enhancing drugs or the prohibition of performance-enhancing methods.

Passed the House of Representatives April 14, 2021.

Cheryl L. Johnson,

Clerk.